Effect of NaBH4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin

Biotechnology Progress

Volumn 20, Issue 3, 2004, Pages 946-952

  Eike, Julie H ^a   Palmer, Andre F ^a  

^a University of Notre Dame   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTES; CHEMICAL BONDS; DISPERSIONS; FRACTIONATION; HEMOGLOBIN; MOLECULAR WEIGHT DISTRIBUTION; SODIUM COMPOUNDS;

HILL COEFFICIENT; OXYGEN BINDING PROPERTIES; POLYMERIZED HEMOGLOBIN DISPERSIONS;

BIOTECHNOLOGY;

BOVINAE;

BLOOD SUBSTITUTE; BORANE DERIVATIVE; GLUTARALDEHYDE; HEMOGLOBIN; MULTIPROTEIN COMPLEX; OXYGEN; POLYMER; SODIUM BOROHYDRIDE;

ANIMAL; ARTICLE; CATTLE; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; KINETICS; MATERIALS TESTING; MOLECULAR WEIGHT; OXIDATION REDUCTION REACTION; PROTEIN BINDING; PROTEIN CONFORMATION; TIME;

ANIMALS; BLOOD SUBSTITUTES; BOROHYDRIDES; CATTLE; GLUTARAL; HEMOGLOBINS; KINETICS; MATERIALS TESTING; MOLECULAR WEIGHT; MULTIPROTEIN COMPLEXES; OXIDATION-REDUCTION; OXYGEN; POLYMERS; PROTEIN BINDING; PROTEIN CONFORMATION; TIME FACTORS;

EID: 2942700266     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0343155     Document Type: Article

References (41)

1. Meng, F. T.; Zhang, W. Z.; Ma, G. H.; Su, Z. G. The preparation and characterization of monomethoxypoly(ethylene glycol)b-poly-DL-lactide microcapsules containing bovine hemoglobin. Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 2003, 31, 279-292.
2. Day, T. K. Current development and use of hemoglobin-based oxygen-carrying (HBOC) solutions. J. Vet. Em. Crit. Care 2003, 13, 77-93.
3. Driessen, B.; Jahr, J. S.; Lurie, F.; Golkaryeh, M. S.; Gunther, R. A. Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: A dose-response study. Crit. Care Med. 2003, 31, 1771-1779.
4. Norris, E. J.; Ness, P. M.; Williams, G. M. Use of a human polymerized hemoglobin solution as an adjunct to acute normovolemic hemodilution during complex abdominal aortic reconstruction. J. Clin. Anesth. 2003, 15, 220-223.
5. Chang, T. M. S. Artificial cells for replacement of metabolic organ functions. Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 2003, 31, 151-161.
6. Vin, R.; Bedenice, D.; Rentko, V. T.; Paradis, M. R. The use of ultrapurified bovine hemoglobin solution in the treatment of two cases of presumed red maple toxicosis in a miniature horse and a pony. J. Vet. Em. Crit. Care 2002, 12, 169-175.
7. Winslow, R. M. Current status of blood substitute research: towards a new paradigm. J. Intern. Med. 2003, 253, 508-517.
8. 125-albumin in the mouse. Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 2000, 28, 451-475.
9. Chan, W. L.; Tang, N. L. S.; Yim, C. C. W.; Lai, F. M.; Tam, M. S. C. New features of renal lesion induced by stroma free hemoglobin. Toxicol. Pathol. 2000, 28, 635-642.
10. Hess, J. R.; Reiss, R. F. Resuscitation and the limited utility of the present generation of blood substitutes. Transfus. Med. Rev. 1996, 10, 276-285.
11. Bleeker, W. K.; Plas, J. V. D.; Feitsma, R. I. J.; Agterberg, J.; Rigter, G.; Rossen, A. D. V.-V.; Pauwels, E. K. J.; Bakker, J. C. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5′-phosphate. J. Lab. Clin. Med. 1989, 113, 151-161.
12. Greenburg, A. G.; Maffuid, P. W. Modification of hemoglobin-ring opened dials. Adv. Blood Substitute Res. 1983, 122, 9-17.
13. Kim, H. W.; Tai, J.; Greenburg, A. G. Alpha adrenergic activation and hemoglobin mediated contraction in the isolated rat thoracic aorta. Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 2001, 29, 367-380.
14. Lieberthal, W. Renal effects of hemoglobin-based blood substitutes. In Red Blood Cell Substitutes; Rudolph, A. S., Rabinovici, R., Feuerstein, G. Z., Eds.; Marcel Dekker: New York, 1998; pp 189-217.
15. Lipfert, B.; Standl, T.; Dullmann, J.; Helmchen, U.; Esch, J. S. A.; Lorke, D. E. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch. Lab. Invest. 1999, 79, 573-582.
16. Riess, J. Oxygen carriers. Chem. Rev. 2001, 101, 2797-2919.
17. De Figueiredo, L. F. P. Vasoactive properties of synthetic blood substitutes. Medicina (Buenos Aires) 1998, 58, 403-410.
18. deFigueiredo, L. F. P.; Mathru, M.; Solanki, D.; MacDonald, V. W.; Hess, J.; Kramer, G. C. Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes. J. Trauma: Inj., Infect., Crit. Care 1997, 42, 847-854.
19. Muldoon, S. M.; Ledvina, M. A.; Hart, J. L.; MacDonald, V. W. Hemoglobin-induced contraction of pig pulmonary veins. J. Lab. Clin. Med. 1996, 128, 579-583.
20. Ortegon, D. P.; Davis, M. R.; Dixon, P. S.; Smith, D. L.; Josephs, J. D.; Mueller, D. L.; Jenkins, D. H.; Kerby, J. D. The polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) is not toxic to neural cells in culture. J. Trauma: Inj., Infect., Crit. Care 2002, 53, 1068-1072.
21. Panter, S. S.; Regan, R. F. Interactions of hemoglobin with the central nervous system. In Red Blood Cell Substitutes; Rudolph, A. S., Rabinovici, R., Feuerstein, G. Z., Eds.; Marcel Dekker: New York, 1998; pp 219-235.
22. Regan, R. F.; Panter, S. S. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci. Lett. 1993, 153, 219-222.
23. Hu, T.; Su, Z. G. Preparation of well-defined bovine polyhemoglobin based on dimethyl adipimidate and glutaraldehyde cross-linkage. Biochem. Biophys. Res. Commun. 2002, 293, 958-961.
24. Alayash, A. I.; Summers, A. G.; Wood, F.; Jia, Y. P. Effects of glutaraldehyde polymerization on oxygen transport and redox properties of bovine hemoglobin. Arch. Biochem. Biophys. 2001, 391, 225-234.
25. Sakai, H.; Yuasa, M.; Onuma, H.; Takeoka, S.; Tsuchida, E. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: Objective comparison between cellular and acellular types. Bioconjugate Chem. 2000, 11, 56-64.
26. Doyle, M. P.; Apostol, I.; Kerwin, B. A. Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties. J. Biol. Chem. 1999, 274, 2583-2591.
27. Beauchamp, R. O.; Clair, M. B. G. S.; Fennell, T. R.; Clarke, D. O.; Morgan, K. T. A critical review of the toxicology of glutaraldehyde. Crit. Rev. Toxicol. 1992, 22, 143-174.
28. Simoni, J.; Simoni, G.; Feola, M. Chromatographic analysis of biopolymers distribution in "poly-hemoglobin", an inter-molecularly cross-linked hemoglobin solution. Anal. Chim. Acta 1993, 279, 73-88.
29. Johnson, J. L.; Moore, E. E.; Gonzalez, R. J.; Fedel, N.; Partrick, D. A.; Silliman, C. C. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. J. Trauma: Inj., Infect., Crit. Care 2003, 54, 133-139.
30. Lanzkron, S.; Moliterno, A. R.; Norris, E. J.; Gould, S. A.; Segal, J.; Nuermberger, E. L.; Ness, P. M. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion 2002, 42, 1422-1427.
31. Gould, S. A.; Moore, E. E.; Hoyt, D. B.; Ness, P. M.; Norris, E. J.; Carson, J. L.; Hides, G. A.; Freeman, I. H. G.; DeWoskin, R.; Moss, G. S. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J. Am. Coll. Surg. 2002, 195, 445-452.
32. Levy, J. H.; Goodnough, L. T.; Greilich, P. E.; Parr, G. V. S.; Stewart, R. W.; Gratz, I.; Wahr, J.; Williams, J.; Comunale, M. E.; Doblar, D.; Silvay, G.; Cohen, M.; Jahr, J. S.; Vlahakes, G. J. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J. Thorac. Cardiovasc. Surg. 2002, 124, 35-42.
33. Williams, J. P.; Tseuda, K.; Vandermeersch, E.; Bourke, D. L.; Jahr, J. S. Transfusion requirements in phase III study of HBOC-201 (Hemopure, hemoglobin glutamer-250, bovine), a bovine hemoglobin based blood substitute. Transfusion 2002, 42, 14S-14S.
34. Nacharaju, P.; Acharya, A. S. Amadori rearrangement potential of hemoglobin at its glycation sites is dependent on the 3-dimensional structure of protein. Biochemistry 1992, 31, 12673-12679.
35. Acharya, A. S.; Roy, R. P.; Dorai, B. Aldimine to ketoamine isomerization (amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin-a - preferential inhibition of glycation by nucleophiles at sites of low isomerization potential. J. Protein Chem. 1991, 10, 345-358.
36. DeVenuto, F.; Zuck, T. F.; Zegna, A. I.; Moores, W. Y. Characterisitcs of stroma-free hemoglobin prepared by crystallization. J. Lab. Clin. Med. 1977, 89, 509-516.
37. Oser, B. L. Hawk's Physiological Chemistry; McGraw-Hill Book Company: New York, 1965.
38. Arifin, D. R.; Palmer, A. F. Determination of size distribution and encapsulation efficiency of liposome encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle light scattering. Biotechnol. Prog. 2003, 19, 1798-1811.
39. Viebke, C.; Williams, P. A. The influence of temperature on the characterization of water-soluble polymers using asymmetric flow field-flow-fractionation couple to multiangle laser light scattering. Anal. Chem. 2000, 72, 3896-3901.
40. Andersson, M.; Wittgren, B.; Wahlund, K.-G. Ultrahigh molar mass component detected in ethylhydroxylethyl cellulose by asymmetric flow field-flow fractionation coupled to multiangle light scattering. Anal. Chem. 2001, 73, 4852-4861.
41. DeVenuto, F.; Zegna, A. Preparation and evaluation of pyridoxalated-polymerized human hemoglobin. J. Surg. Res. 1983, 34, 205-212.